Purchase of MALDI Biotyper

The Food and Drug Administration is seeking to purchase a MALDI Biotyper system to replace an unserviceable Bruker biotyper system within the SA lab. This equipment utilizes MALDI-TOF MS technology to facilitate the rapid identification of bacteria, specifically for the identification of Clostridium botulinum and its associated neurotoxin. This procurement is currently listed as a forecast under NAICS code 541990. The acquisition is being managed by the Food and Drug Administration, with the Hfp Acquisition Liaison serving as the program point of contact.